Effect of multivitamin supplementation on the neurodevelopment of HIV-exposed Tanzanian infants: a randomized, double-blind, placebo-controlled clinical trial

J Trop Pediatr. 2014 Aug;60(4):279-86. doi: 10.1093/tropej/fmu011. Epub 2014 Feb 24.

Abstract

Background: Micronutrient deficiencies and in utero exposure to HIV may impair infant neurodevelopment.

Objective: To evaluate the effect of daily multivitamin supplementation on the cognitive, language and motor development of HIV-exposed Tanzanian infants.

Methods: A total of 2387 infants were randomized to receive daily oral supplementation of multivitamins (B-complex, C and E) or placebo from age 6 weeks for 24 months. The cognitive, language and motor scales of the Bayley Scales of Infant and Toddler Development, third edition, were administered to a subset of 206 infants at age 15 months.

Results: Multivitamin supplementation did not improve measures of cognitive development, expressive or receptive language or gross motor capabilities. There was a trend toward improved fine motor skills among infants randomized to the multivitamin group (difference in mean score = 0.38; 95% CI = -0.01, 0.78, p = 0.06).

Conclusion: Daily provision of multivitamins to HIV-exposed infants does not substantially improve developmental outcomes at age 15 months.

Keywords: HIV; Multivitamins; infant development.

Publication types

  • Randomized Controlled Trial
  • Research Support, N.I.H., Extramural

MeSH terms

  • Child Development / drug effects*
  • Cognition
  • Dietary Supplements*
  • Double-Blind Method
  • Female
  • HIV Infections / complications
  • HIV Infections / transmission*
  • Humans
  • Infant
  • Infectious Disease Transmission, Vertical*
  • Language Development
  • Male
  • Motor Skills
  • Nervous System / drug effects*
  • Nervous System / growth & development
  • Pregnancy
  • Pregnancy Complications, Infectious / virology
  • Treatment Outcome
  • Vitamins / administration & dosage*

Substances

  • Vitamins